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Abstract
Background: Mammal macrophages (MΦ) display a wide range of functions which contribute to
surveying and maintaining tissue integrity. One such function is phagocytosis, a process known to
be subverted by parasites like Leishmania (L). Indeed, the intracellular development of L. amazonensis
amastigote relies on the biogenesis and dynamic remodelling of a phagolysosome, termed the
parasitophorous vacuole, primarily within dermal MΦ.
Results: Using BALB/c mouse bone marrow-derived MΦ loaded or not with amastigotes, we
analyzed the transcriptional signatures of MΦ 24 h later, when the amastigote population was
growing. Total RNA from MΦ cultures were processed and hybridized onto Affymetrix
Mouse430_2 GeneChips®, and some transcripts were also analyzed by Real-Time quantitative PCR
(RTQPCR). A total of 1,248 probe-sets showed significant differential expression. Comparable
fold-change values were obtained between the Affymetrix technology and the RTQPCR method.
Ingenuity Pathway Analysis software® pinpointed the up-regulation of the sterol biosynthesis
pathway (p-value = 1.31e-02) involving several genes (1.95 to 4.30 fold change values), and the
modulation of various genes involved in polyamine synthesis and in pro/counter-inflammatory
signalling.
Conclusion: Our findings suggest that the amastigote growth relies on early coordinated gene
expression of the MΦ lipid and polyamine pathways. Moreover, these MΦ hosting multiplying L.
amazonensis amastigotes display a transcriptional profile biased towards parasite-and host tissue-
protective processes.
Background
L. amazonensis are protozoan parasites belonging to the
trypanosomatidae family. In natural settings, the L. ama-
zonensis perpetuation relies on blood-feeding sand fly and
rodent hosts. The development of promastigotes proceeds
within the gut lumen of the sand fly hosts and ends with
metacyclic promastigotes. The latter, once delivered into
the mammal dermis, differentiate as amastigotes mainly
within the resident dermal macrophage (MΦ) acting as
bona fide host cells. Following the parasite inoculation and
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before the development of the more or less transient skin
damages that characterize cutaneous leishmaniasis there
is an asymptomatic phase lasting for several days or weeks
during which the intracellular amastigote progeny
expands. This expansion takes place within a compart-
ment named parasitophorous vacuole (PV) that displays
properties similar to late endosomes/lysosomes and the
size of which grows significantly for Leishmania belonging
to the mexicana complex [1,2]. In this study we sought to
analyze the transcriptional signatures of a homogeneous
population of MΦ derived in vitro from BALB/c mouse
bone marrow CSF-1 dependent progenitors and hosting
amastigotes that are actively multiplying. The Affymetrix
GeneChip technology was used to compare the gene
expression profiles of L. amazonensis amastigotes-hosting
bone marrow-derived MΦ and parasite-free ones. This in
vitro  transcriptomics approach was combined with the
Ingenuity biological network analysis to highlight the
mouse MΦ biological processes the multiplying L. amazo-
nensis amastigotes rely on within their giant communal
PV. Our findings suggest that MΦ hosting multiplying
amastigotes contribute to carve a parasite-as well as a host
tissue-protective environment.
Results and Discussion
L. amazonensis amastigotes subvert MΦ as host cells where
they enter a cell-cycling phase lasting several days (Fig.
1A). We compared the transcriptomes of amastigote-free
MΦ and amastigote-harbouring MΦ 24 h after the uptake
of amastigotes carefully purified from nude mouse
lesions. At this time-point amastigotes were multiplying
within a huge PV (Fig. 1B) and their population size had
almost doubled (Fig. 1A). Among the 45,101 probe-sets
of the Mouse430_2 GeneChip, 1,248 (2.77%) were dis-
playing features of differential expression at the 5% signif-
icance level (Fig. 2, see Additional file 1). Of these, 1,206
matched Ingenuity Pathway Analysis database version
5.5.1 which represented 898 genes with a known func-
tion. About 80% of these genes were incorporated into
either Ingenuity's canonical pathway or biological net-
work (i.e. their products interact with other molecules in
Ingenuity's knowledge base). The symbols of the modu-
lated genes are specified in the text (fold change [FC] val-
ues between brackets), while their full names are given in
Additional file 1. Furthermore, comparable FC values
were obtained between the Affymetrix technology and the
Real Time quantitative Polymerase Chain Reaction
(RTQPCR) method (Table 1) [3].
Though transcriptional changes due to the phagocytic
uptake process per se – known to occur mostly within the
first 2 hours post particle addition – cannot be completely
excluded, the MΦ transcript modulation – detected at 24
h post the amastigote addition – very likely reflects MΦ
reprogramming due to the presence of cell cycling amas-
tigotes within giant PV. Indeed, in our experimental con-
ditions, no extracellular amastigotes could be evidenced
in the MΦ culture (a) after a brief centrifugation step and
(b) one hour contact with adherent MΦ indicating that
the phagocytic uptake of L. amazonensis amastigotes is a
rapid and efficient process. Furthermore, it is worth men-
tioning that the size of the amastigote population hosted
within the MΦ PV rapidly expands within the first 24 h
(Fig. 1A) [4]. Using also mouse bone marrow-derived MΦ
as host cells for Leishmania, Gregory and coworkers dem-
onstrated that the gene expression profiles of control MΦ
and MΦ that have phagocytosed latex beads 24 h before
were very similar. They evidenced a statistically significant
difference for only 15 probe sets. None of the 29 corre-
sponding probe sets in the mouse 430 DNA Affymetrix
gene chip was present in the list of 1248 modulated probe
sets observed in presence of L. amazonensis amastigotes.
Thus, these data strongly support our conclusion that the
gene expression profile observed 24 h after the phagocyto-
sis of L. amazonensis amastigotes was due to the presence
of intracellular cell-cycling parasites.
L. amazonensis amastigotes set up an optimal sub cellular 
niche
Modulation of MΦ genes encoding vacuolar proton ATPase sub-units
Within their host cells, L. amazonensis amastigotes are
known to multiply efficiently in the acidic environment of
the MΦ PV [1]. In presence of amastigotes, we observed an
up-regulation of the gene expression of eight isoforms of
the V0 and V1 sub-units of the MΦ vacuolar proton
ATPase (atp6V0a1, atp6V0c, atp6V0d2, atp6V1a, atp6V1c1,
atp6V1d, atp6V1g1 and atp6V1h: +1.27 < FC < +2.32) [5].
This could contribute to the sustained acidification of the
PV lumen which has been shown to be important at least
for the optimal amastigote nutrient acquisition [6,7].
Coordinated modulation of MΦ lipid metabolism
The most relevant biological networks fitting our dataset
were strongly associated to the function "lipid metabo-
lism", the most significant canonical metabolic pathway
being "biosynthesis of steroids" (p-value = 1.31e-02).
Indeed, several up-regulated genes (Fig. 3, Table 1) were
involved i) in cholesterol uptake (ldlr: + 4.68), ii) in cho-
lesterol transport (fabp4: + 6.42 and stard4: + 2.31) and iii)
in sterol biosynthesis (hmgcs1, hmgcr, mvd, idi1, fdps, fdft1,
sqle, lss, cyp51, sc4mol, hsd17b7, sc5d and dhcr24: +1.95 <
FC < +4.30). Worth is mentioning the most up-regulated
gene encoding type II deiodinase (dio2, + 25.92), an
enzyme converting intracellular thyroxin (T4) to tri-
iodothyronine (T3), the more active form of thyroid hor-
mone. It has previously been demonstrated in mouse
hepatocytes that the molecular basis for the connection of
T3 and cholesterol metabolism involves the master tran-
scriptional activator of the aforementioned genes, namely
srebf2 (+ 1.84) the promoter of which contains a thyroidBMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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Table 1: List of differentially expressed genes between L. amazonensis-harbouring MΦ and parasite-free MΦ.
Symbol Name Probe-set LocusLink Affymetrix (RTqPCR) P-value
abcD2 ATP-binding cassette, sub-family D (ALD), member 2 1438431_ata 26874 -2.11 4.40e-03
acaca acetyl-Coenzyme A carboxylase alpha 1427595_at 107476 -1.32 4.79e-03
acsl3 acyl-CoA synthetase long-chain family member 3 1452771_s_at 74205 +2.09 1.48e-03
adhfe1 alcohol dehydrogenase, iron containing, 1 1424393_s_at 76187 +1.61 4.40e-02
akr1a1 aldo-keto reductase family 1, member A1 (aldehyde reductase) 1430123_a_at 58810 +1.13 1.22e-03
aldoA aldolase 1, A isoform 1433604_x_ata 11674 +1.72 1.28e-02
aldoC aldolase 3, C isoform 1451461_a_at 11676 +1.89 1.13e-02
anxA1 annexin A1 1444016_ata 16952 +2.68 4.47e-05
apoc2 apolipoprotein C-II 1418069_at 11813 -1.63 4.57e-02
arg2 Arginase 2 1418847_at 11847 NM (+1.91) NS
atf1 activating transcription factor 1 1417296_at 11908 +1.84 4.20e-03
atf3 activating transcription factor 3 1449363_at 11910 +1.77 1.09e-02
atp6V0a1 ATPase, H+ transporting, lysosomal V0 subunit a isoform 1 1460650_ata 11975 +1.82 8.31e-03
atp6V0c ATPase, H+ transporting, V0 subunit C 1435732_x_at 11984 +1.27 5.48e-13
atp6V0d2 ATPase, H+ transporting, V0 subunit D, isoform 2 1444176_ata 24234 +2.32 1.12e-05
atp6V1a ATPase, H+ transporting, V1 subunit A1 1422508_at 11964 +1.57 3.96e-02
atp6V1c1 ATPase, H+ transporting, V1 subunit C, isoform 1 1419546_ata 66335 +2.31 1.10e-05
atp6V1d ATPase, H+ transporting, V1 subunit D 1416952_ata 73834 +1.82 6.97e-03
atp6V1g1 ATPase, H+ transporting, V1 subunit G isoform 1 1423255_ata 66290 +1.84 3.78e-03
atp6V1h ATPase, H+ transporting, lysosomal, V1 subunit H 1415826_at 108664 +1.69 2.39e-02
azin1 antizyme inhibitor 1 1422702_at 54375 +1.96 1.46e-03
brd8 bromodomain containing 8 1427193_at 78656 +1.08 3.75e-02
c1qa complement component 1, q subcomponent, alpha polypeptide 1417381_at 12259 -1.48 3.15e-02
c1qb complement component 1, q subcomponent, beta polypeptide 1417063_at 12260 -1.77 3.31e-04
c3 complement component 3 1423954_at 12266 -2.37 7.05e-06
c4b complement component 4 (within H-2S) 1418021_at 12268 -1.76 4.55e-02
c5ar1 complement component 5a receptor 1 1439902_at 247623 -1.63 4.62e-02
ccr2 chemokine (C-C motif) receptor 2 1421187_ata 12772 -1.83 (-2.35) 6.42e-03
ccr3 chemokine (C-C motif) receptor 3 1422957_at 12771 -2.58 (-3.88) 2.49e-05
cd14 CD14 antigen 1417268_at 12475 -1.73 1.54e-03
cd200 CD200 antigen 1448788_at 17470 +4.14 (+6.52) 5.48e-13
cd274 CD274 antigen 1419714_at 60533 +1.93 1.61e-03
cd86 CD86 antigen 1420404_ata 12524 -1.83 (-1.03) 1.44e-02
cfh complement component factor h 1450876_at 12628 -2.80 6.08e-06
c-fos FBJ osteosarcoma oncogene 1423100_at 14281 -1.93 3.30e-03
ch25h cholesterol 25-hydroxylase 1449227_at 12642 -6.57 1.39e-22
cmklr1 chemokine-like receptor 1 1456887_at 14747 -2.20 1.57e-04
cx3cr1 chemokine (C-X3-C) receptor 1 1450020_at 13051 -2.65 (-5.26) 2.39e-05
cyp51 cytochrome P450, family 51 1450646_ata 13121 +2.78 2.10e-07
dhcr24 24-dehydrocholesterol reductase 1451895_a_at 74754 +3.17 2.69e-09
dio2 deiodinase, iodothyronine, type II 1418937_ata 13371 +25.92 (+41.03) 0.00e+00
eno2 enolase 2, gamma neuronal 1418829_a_at 13807 +2.60 6.08e-06
fabp3 fatty acid binding protein 3 1416023_at 14077 +2.29 5.58e-05
fabp4 fatty acid binding protein 4 1417023_a_ata 11770 +6.42 0.00e+00
fabp5 fatty acid binding protein 5 1416022_ata 16592 +1.57 4.70e-08
fbp1 fructose bisphosphatase 1 1448470_at 14121 -2.16 4.68e-03
fdft1 farnesyl diphosphate farnesyl transferase 1 1438322_x_ata 14137 +2.62 4.00e-06
fdps farnesyl diphosphate synthetase 1423418_at 110196 +3.59 9.78e-12
h-2ma histocompatibility 2, class II, locus DMa 1422527_at 14998 -1.88 3.00e-03
h60 histocompatibility 60 1439343_at 15101 -2.07 5.30e-09
hk2 hexokinase 2 1422612_at 15277 +1.75 1.09e-02
hk3 hexokinase 3 1435490_at 212032 +2.03 3.72e-04
hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase 1427229_at 15357 +1.95 2.34e-03
hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 1433446_at 208715 +2.48 1.07e-06
hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 1457248_x_at 15490 +2.73 1.41e-05
icam1 intercellular adhesion molecule 1424067_at 15894 -1.75 1.43e-02
icam2 intercellular adhesion molecule 2 1448862_at 15896 -1.85 2.88e-02
idi1 isopentenyl-diphosphate delta isomerase 1451122_ata 319554 +2.72 2.77e-07
ifngr1 interferon gamma receptor 1 1448167_at 15979 -1.83 (-2.16) 4.66e-03BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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il10 interleukin 10 1450330_at 16153 -2.97 (-4.46) 1.11e-07
il10ra interleukin 10 receptor, alpha 1448731_at 16154 -2.16 (-2.56) 4.40e-04
il11ra1 interleukin 11 receptor, alpha chain 1 1417505_s_at 16157 +2.24 (+3.55) 9.89e-05
il17rb interleukin 17 receptor B 1420678_a_at 50905 -1.41 2.93e-02
il18 interleukin 18 1417932_at 16173 -1.77 (-2.12) 1.06e-02
il1b interleukin 1 beta 1449399_a_at 16176 -3.09 (-5.17) 3.49e-07
il1rn interleukin 1 receptor antagonist 1423017_a_ata 16181 +4.19 (+7.86) 0.00e+00
insig1 insulin induced gene 1 1454671_at 231070 +2.62 9.17e-08
itga4 integrin alpha 4 1456498_ata 16401 -2.06 2.37e-03
itgal integrin alpha L 1435560_at 16408 -2.00 7.72e-03
klrk1 killer cell lectin-like receptor subfamily K, member 1 1450495_a_at 27007 -1.72 2.21e-02
ldhA lactate dehydrogenase 1, A chain 1419737_a_at 16828 +1.79 2.71e-04
ldlr low density lipoprotein receptor 1450383_ata 16835 +4.68 1.49e-13
lipe lipase, hormone sensitive 1422820_at 16890 -2.20 2.90e-03
lpl lipoprotein lipase 1431056_a_at 16956 -1.44 3.24e-02
lss lanosterol synthase 1420013_s_at 16987 +2.05 2.29e-03
maoa monoamine oxidase A 1428667_ata 17161 +2.56 4.71e-06
mapk14 mitogen activated protein kinase 14 (p38 mapk) 1416703_at 26416 -1.61 4.97e-02
mgll monoglyceride lipase 1426785_s_at 23945 +3.40 3.75e-08
mvd mevalonate (diphospho) decarboxylase 1417303_ata 192156 +2.15 6.33e-04
ncoa4 nuclear receptor coactivator 4 1450006_at 27057 +1.65 3.15e-02
nfkbia nuclear factor of kappa light chain gene enhancer in B-cells 
inhibitor, alpha
1448306_at 18035 -1.83 5.53e-03
nos2 nitric oxide synthase 2, inducible, macrophage 1420393_at 18126 NM (+1.28) NS
odc1 Ornithine decarboxylase 1 1427364_a_at 18263 NM (+1.18) NS
p4ha2 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), α II polypeptide
1417149_at 18452 +2.27 1.96e-03
pfkl phosphofructokinase, liver, B-type 1439148_a_at 18641 +1.68 2.32e-02
pkg1 phosphoglycerate kinase 1 1417864_at 18655 +1.70 8.88e-03
pkm2 pyruvate kinase, muscle 1417308_at 18746 +1.51 4.57e-02
ppap2B phosphatidic acid phosphatase type 2B 1448908_ata 67916 +8.53 0.00e+00
pros1 protein S (alpha) 1426246_at 19128 -2.09 2.66e-03
relb avian reticuloendotheliosis viral (v-rel) oncogene related B 1417856_at 19698 -1.91 1.94e-02
sat1 spermidine/spermine N1-acetyl transferase 1 1420502_at 20229 +1.47 2.30e-02
sc4mol sterol-C4-methyl oxidase-like 1423078_a_at 66234 +2.28 1.61e-05
sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) 
homolog (S. cerevisae)
1451457_ata 235293 +2.57 2.37e-06
scd1 stearoyl-Coenzyme A desaturase 1 1415964_ata 20249 +2.68 4.50e-05
scd2 stearoyl-Coenzyme A desaturase 2 1415824_ata 20250 +2.45 1.32e-06
serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 1416625_at 12258 -1.35 4.84e-05
slc7a2 solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 2
1436555_ata 11988 +4.14 6.07e-12
sms spermine synthase 1434190_ata 20603 NM [-1.38b]N S
socs6 suppressor of cytokine signaling 6 1450129_a_at 54607 +1.84 4.18e-03
sqle squalene epoxidase 1415993_at 20775 +4.30 0.00e+00
srebf2 sterol regulatory element binding factor 2 1426744_at 20788 +1.84 1.26e-02
srm spermidine synthase 1421260_a_at 20810 NM [-1.22b]N S
stard4 StAR-related lipid transfer (START) domain containing 4 1429239_a_ata 170459 +2.31 2.43e-04
tlr2 toll-like receptor 2 1419132_at 24088 -3.11 (-1.58) 1.83e-08
tlr7 toll-like receptor 7 1449640_at 170743 -1.77 (-1.07) 4.61e-02
tlr8 toll-like receptor 8 1450267_at 170744 -1.79 1.00e-02
tollip toll interacting protein 1423048_a_at 54473 +1.69 3.57e-02
This table is an excerpt from the table of the 1,248 significantly modulated probe-sets, available as online Additional file 1, and contains some genes 
tested by RTQPCR.
a when several probe-sets detect a target gene, data are only shown for the most modulated one. NM: No Modulation significantly detected with 
Affymetrix technology. NS: Not Significant p-value. b mean values obtained from the raw fluorescence intensities.
Table 1: List of differentially expressed genes between L. amazonensis-harbouring MΦ and parasite-free MΦ. (Continued)BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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hormone response element [8]. Furthermore, thyroid hor-
mone receptors can activate transcription of target genes
upon T3 binding and this could be facilitated by co-acti-
vators  ncoa4  (+ 1.65) and brd8  (+ 1.08). Interestingly,
opposite to dio2, the most down-regulated gene was cho-
lesterol-25-hydrolase (ch25h: -6.57), an enzyme acting
downstream this pathway by breaking down cholesterol
and by synthesizing a co-repressor of srebf2 transcriptional
activation [9]. Upstream this pathway, several up-regu-
lated genes involved in glycolysis could also contribute to
increase the supply of acetate (acsl3, adhfe1, akr1a1, aldoa,
aldoc, eno2, hk2, hk3, ldha, pfkl, pkg1 and pkm2: +1.13 < FC
< +2.61). Of note was the down-regulation of genes
encoding enzymes competing i) with hmgcs1 for acetate
(acaca: -1.32) and ii) with aldoa and aldoc for fructose, 1-
6, biphosphate, which is needed to produce glyceralde-
hyde-3-phosphate upstream the sterol biosynthesis path-
way (fbp1: -2.16). In addition, the up-regulation of the
transcription factor encoded by atf3 (+ 1.77) was consist-
ent with the down-modulation of fbp1. These data suggest
that the available intracellular pool of sterol-synthesis
molecular intermediates was maintained by a gene expres-
sion program relying on a coordinated regulation at both
the transcriptional level by srebf2, atf1 (+ 1.84) and atf3,
and also most likely at the post-transcriptional level by
insig1 (+ 2.62) encoding a sterol-sensing protein that reg-
ulates the intracellular cholesterol level [10].
The expression of several genes involved in the fatty acid
biosynthesis pathway was also up-regulated with the
modulation of ppap2b  (+ 8.53), scd1  (+ 2.68), scd2  (+
2.45) and acsl3 (+ 2.09). Moreover, genes encoding fatty
acid binding proteins that play a role in fatty acid uptake
and transport were up-regulated (fabp3: + 2.29, fabp4: +
Time course of intracellular amastigote population size increase and MΦ culture imaging Figure 1
Time course of intracellular amastigote population size increase and MΦ culture imaging. A: time course experi-
ment showing the evolution of the amastigote population within MΦ. Mean number of amastigotes per MΦ were plotted 
against the time points selected. Ten microscope fields split up into biological duplicates were visualized and more than 200 
MΦ nuclei were counted. B: L. amazonensis-housing bone marrow-derived MΦ imaged 24 h post amastigote (4 parasites per 
MΦ) addition. Nuclei were stained with Hoechst (blue) and amastigote with 2A3.26 mAb and Texas Red-labelled conjugate 
(red). Image acquisition was performed using an immunofluorescence and differential interference contrast inverted micro-
scope (Zeiss Axiovert 200 M). Asterisk: Parasitophorous vacuoles; arrow heads: Amastigotes.BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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6.42 and fabp5: + 1.57). Extracellular lipolysis was down-
modulated (lipe: -2.20, lpl: -1.44 and apoc2: -1.63), while
intracellular catabolism of triglycerides mediated via mgll
was up-regulated (+ 3.40). Fatty acid transport to peroxi-
some was diminished with abcd2  down-modulation (-
2.11). Since this was not described neither for L. major nor
L. donovani [11], this could be unique for the L. mexicana
complex, all sub-species of which multiply within giant
communal PV [1]. Indeed, previous experimental work
performed with L. mexicana [12,13], which is very close to
L. amazonensis (both share the same distinctive feature to
multiply within a communal PV), has shown that amas-
tigotes could take advantage of the MΦ sterol biosynthesis
pathway to produce ergosterol.
These data were in agreement with the sterol biosynthesis
machinery of the MΦ host cell being exploited by the cell-
cycling amastigotes for both their own cell membrane
sterols, in particular ergosterol and the PV membrane
sterol-dependent remodelling. Indeed, cholesterol availa-
bility might play a role in the formation of the PV lipid
rafts [14] that could be involved in the control of fusion
events leading to the sustained remodelling of the huge
communal PV membrane where the aforementioned pro-
ton pump components are regularly delivered.
Modulation of MΦ polyamine metabolism
Polyamines (e.g. putrescine) derived from arginine catab-
olism are essential compounds for amastigote growth
Affymetrix outcome Figure 2
Affymetrix outcome. A: Volcano plot. 1,248 probe-sets 
showed differential expression at the 0.05 threshold (green 
line): 605 positive and 643 negative FC values of which 454 in 
the right and 507 in the left upper corners (± 1.75 FC thresh-
old, red lines, blue circles). B: Fold-change distribution of the 
1,248 probe sets.
Modulation of the sterol biosynthesis pathway in L. amazon- ensis-hosting MΦ Figure 3
Modulation of the sterol biosynthesis pathway in L. 
amazonensis-hosting MΦ. L. amazonensis-hosting MΦ dis-
play an up-regulation of several genes involved in sterol bio-
synthesis (*, at least 2 probe-sets modulated).BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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[15]. Using the Affymetrix technology we failed to detect,
at the 5% significance threshold, arginase-2 (arg2) and
ornithine decarboxylase-1 (odc1), two enzymes leading to
the formation of polyamines through arginine catabo-
lism. Indeed, while for arg2 the raw fluorescence intensity
values were below or close to the background level, for
odc1 the raw fluorescence intensities before data process-
ing displayed only a slight increase (+ 1.21) in presence of
amastigotes (see Additional file 1). However, the up-regu-
lation of SLC7A2 (+ 4.14) in MΦ hosting amastigotes was
a strong incentive for monitoring the abundance of arg2
and odc1 transcripts with a validated RTQPCR method.
Using this method we did detect a slight variation of the
expression of arg2 (+ 1.91) and odc1 (+ 1.18) (Table 1).
Therefore, in presence of amastigotes, arg2 could favour
arginine transformation into ornithine, the latter being
catalyzed in turn by odc1 to generate putrescine (Fig. 4).
ODC1-antizyme plays a role in the regulation of
polyamine synthesis by binding to and inhibiting ODC1.
The transcript abundance of azin1  encoding ODC1-
antizyme inhibitor-1 was higher (+ 1.96) when amastig-
otes were present, so that this inhibitor might prevent
antizyme-mediated ODC1 degradation. Of note, orni-
thine could also be generated from proline by p4ha2 (+
2.27), and putrescine from spermine and spermidine by
the successive action of sat1 (+ 1.47) and maoa (+ 2.56).
Spermidine synthase (srm) and spermine synthase (sms),
two enzymes catalyzing the reverse reactions leading to
the formation of spermine from putrescine, were not
detected with Affymetrix (5% threshold), although their
transcript abundance decreased in presence of amastig-
otes (-1.22 and -1.38, respectively; see Additional file 1).
No gene expression modulation was detected with
Affymetrix for nos2 (5% threshold) that encodes a com-
peting enzyme for arginine substrate leading to the pro-
duction of microbe-targeting nitric oxide derivatives
(fluorescence intensity was below the background level,
see Additional file 1), and only a slight up-regulation was
detected with RTQPCR (+ 1.28) (Table 1). The present
data further extend former observations [15,16], and
highlight a coordinated gene expression modulation that
sustains a metabolic flux leading to the biosynthesis of
putrescine from arginine and proline via ornithine, and
from spermine and spermidine.
L. amazonensis amastigotes set up an optimal dermis 
niche
Decreased expression of genes involved in the entry of non 
leishmanial micro-organisms as well as in the sensing and processing 
of microbial molecules
Several genes involved in classical and alternate comple-
ment component pathways were down-regulated (c1qa,
c1qb, serping1, c3, c4b, cfh, c5ar1 and pros1: -2.80 < FC < -
Modulation of the polyamine biosynthesis pathways in L. amazonensis-hosting MΦ Figure 4
Modulation of the polyamine biosynthesis pathways in L. amazonensis-hosting MΦ. L. amazonensis-hosting MΦ dis-
play a gene expression coordination of several genes involved in polyamine biosynthesis (*, at least 2 probe-sets modulated; 
blue values determined by RTQPCR).BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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1.35) as well as some genes of the Toll-like receptor signal-
ling pathway (tlr2, tlr7, tlr8, cd14, mapk14, c-fos and nfkbia:
-3.11 < FC < -1.61. Furthermore, the negative regulator tol-
lip also was up-regulated (+ 1.69). These pathways are
known to contribute to the entry of micro-organisms and
the sensing/processing of microbial molecules. In pres-
ence of the intracellular cell-cycling amastigotes these bio-
logical processes would be restricted, if not prevented.
Indeed, it is conceivable that non-Leishmania  micro-
organisms or microbial molecules might trigger a differ-
ent MΦ transcriptional program that could interfere with
the one already set up by L. amazonensis amastigotes for
their multiplication. Nevertheless, it has recently been
demonstrated that the other L. amazonensis developmen-
tal stage, the promastigote, was still able to enter MΦ
already hosting amastigotes, to transform into amastigote
and to multiply efficiently within the PV [17].
The above data suggested that L. amazonensis amastigotes
were able to control MΦ expression of the early comple-
ment components, the proteolytic products of which are
known to be pro-inflammatory. This complement com-
ponent pathway down-modulation was also recently
described for human MΦ housing L. major parasites [18].
The down-modulation of the Toll-like receptor pathway
also suggested prevention of the inflammatory process
signalling. At this stage, although some anti-inflammatory
genes were not up-modulated (il10: -2.97 and il10ra: -
2.16) the gene expression modulation for the majority of
the listed genes involved in inflammatory processes
showed that the presence of cell-cycling amastigotes
imposed an immune unbalance favouring the shaping of
a counter-inflammatory and safe dermis niche for these
parasites (il1rn, il1b, il11ra1, il17rb, il18, socs6, cd200, nfk-
bia, relB, c-fos and anxA1, an inhibitor of phospholipase
A2 mediated-inflammation: 1.41 < | FC | < 4.19).
Decreased expression of genes involved in the chemokine-dependent 
MΦ traffic
The down-modulation of the expression of genes encod-
ing chemokine receptors (ccr2, ccr3, cx3cr1 and cmklr1: -
2.65 < FC < -1.83) suggested that amastigote-harbouring
MΦ were less responsive to chemo-attractant gradients
and thus less amenable to enter into the afferent lymphat-
ics. This is consistent with the dominant residence of L.
amazonensis-hosting MΦ in the skin. In favour of this pos-
sible reduced emigration of MΦ from the dermis niche
was the down-regulation of itga4  (-2.06) encoding an
integrin shown to contribute to the lymphatic adhesion/
transmigration [19]. It is beyond the scope of this article
to discuss about more than a dozen of chemokine recep-
tor ligands the gene expression of which was modulated
(see Additional file 1). Indeed, the interpretation is not
that straightforward because of the complexity of their
partial overlapping functions and/or common receptors.
Decreased expression of genes involved in the cellular 
communication with leukocytes prone to display parasite-damaging 
functions
The modulation of several transcripts indicated a preven-
tion of MΦ communication with leukocytes that could be
rapidly recruited such as NK lymphocytes, and T-lym-
phocytes. For instance, H60 is one of the ligand able to
efficiently activate NK-lymphocytes by binding to the
NKG2D receptor (encoded by klrk1). In presence of amas-
tigotes, the h60 MΦ expression was down-modulated (-
2.07), suggesting the prevention of this "immune syn-
apse" by which parasitized MΦ and NK lymphocytes can
communicate. Interestingly, NKG2D receptor engage-
ment by H60 ligand in MΦ, that normally leads to the
production of MΦ leishmanicidal molecules such as NO
and TNF-α [20], could be impaired in MΦ hosting amas-
tigotes since the expression of klrk1 gene was also down-
modulated (-1.72). Besides, the gene expression of the co-
stimulatory molecule CD86 was reduced (-1.83), while
that of the inhibitory receptor CD274 (also referred to as
B7-H1) was increased (+ 1.93). In addition, the transcript
abundance of the co-stimulatory molecules ICAM1 (-
1.75), ICAM2 (-1.85) and LFA-1 (or integrin-alpha L, –
2.0) was also reduced. The down-modulation of several
genes involved in antigen presentation by MHC class II
molecules was recently discussed for human MΦ housing
L. major parasites [18]. This data suggested plausible
reduced effectiveness of this other "immune synapse"
involving TCR-dependent signalling by which MΦ and T-
lymphocytes can communicate. Consistent with this was
the reduced transcription level in MΦ hosting L. amazon-
ensis amastigotes of h-2ma (-1.88) and of ifngr1 (-1.83 FC)
that encodes the receptor for IFNγ, a cytokine secreted by
both activated NK- and T-lymphocytes and involved
upstream the MHC class II gene up-regulation.
Conclusion
The Affymetrix GeneChip technology has allowed – for
many cell lineages – the global analysis of several thou-
sand transcripts simultaneously to be carried out in a
robust fashion [21]. The remarkable coordination of gene
expression as well as coherent biological interaction net-
works displayed by MΦ subverted as host cells by the mul-
tiplying L. amazonensis amastigotes allow highlighting the
power of this technology at two different levels: (a) the
amastigote-hosting MΦ transcriptional features per se and
(b) the features of MΦ hosting cell-cycling amastigotes
which would have been captured within the dermal envi-
ronment. Further in vivo quantitative analysis will have to
be set up for validating or not the present transcriptional
profile at early stage after the first wave of amastigote mul-
tiplication in the ear dermis of naïve BALB/c mice. Over-
all, the gene expression profile of MΦ hosting amastigotes
did not strictly fall into either of the MΦ "activation" pro-
files, as it was also the case for L. chagasi [22]. Neverthe-BMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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less, consistent with the multiplication of the amastigote
developmental stage, some overlap with features of the
alternative MΦ activation could be observed, such as the
up-regulation of arg2 and il1rn, and the down-regulation
of cd14 (-1.73 FC).
In addition to the conversion of the MΦ arginine metab-
olism from a parasite-damaging pathway to a parasite-
supportive one, the most clear-cut and novel output of the
present analysis was the up-regulation of the MΦ fatty
acid biosynthesis pathway. Coupled to the polyamine
biosynthesis the MΦ lipids could not only be a source of
nutrients for the amastigotes but could also contribute to
the PV unique membrane features [2,23]. Lipids could not
only influence the PV membrane curvature but also coor-
dinate the recruitment and retention of key protein export
to the PV where multiplying amastigotes are known to be
attached [2]. This makes it conceivable that the multiply-
ing amastigotes could take up trophic resources and sense
non-trophic signals.
We have highlighted a promising set of transcripts
accounting for the BALB/c mouse macrophage repro-
grammed as cell-cycling amastigote hosting cells. We do
not ignore that transcript modulation changes revealed by
microarray analysis could be uncoupled to changes
revealed by proteomic and phosphoproteomic analysis.
We did not explore how these mRNA changes manifest at
the level of the proteome but the present genomewide
data will provide a unique resource (a) against which to
compare any proteomic/phosphoproteomic data (b) to
allow identifying novel small compounds displaying
static or cidal activity towards cell-cycling amastigotes
hosted within the macrophage PV. Indeed the readout
assay we designed allows high content imaging in real
time of (a) the amastigotes (b) the amastigotes-hosting PV
as well as the macrophages per se [24] and can be up-
scaled for high throughput screening of small compound
libraries.
Methods
Mice, MΦ and amastigotes
Swiss  nu/nu  and BALB/c mice were used (following
National Scientific Ethics Committee guidelines) for L.
amazonensis (LV79, MPRO/BR/1972/M1841) amastigote
propagation and bone marrow-derived MΦ preparation,
respectively. Four amastigotes per MΦ were added. Para-
site-harbouring MΦ (>98%) and parasite-free ones were
cultured at 34°C either for 24 h for transcriptomic studies
or for different time periods for microscopy analyses [25].
Kinetic study of the intracellular amastigote population 
size
At different time points post amastigote addition, MΦ cul-
tures were processed for immunofluorescence and phase
contrast microscopy. Briefly, MΦ cultures on coverslips
were fixed, permeabilized, incubated with the amastigote-
specific mAb 2A3.26 and Texas Red-labelled conjugate,
stained with Hoechst 33342 and mounted in Mowiol for
observation under an inverted microscope as previously
described [25]. Ratios of amastigotes per MΦ (between
200 and 700 MΦ nuclei being counted) were calculated
and expressed as mean numbers of amastigotes per MΦ at
each time point.
GeneChip hybridization and data analysis
Total RNA were extracted from MΦ (RNeasy+ Mini-Kit,
Qiagen), their quality control (QC) and concentration
were determined using NanoDrop ND-1000 micro-spec-
trophotometer and their integrity was assessed [26] using
Agilent-2100 Bioanalyzer (RNA Integrity Numbers ≥ 9).
Hybridizations were performed following the Affymetrix
protocol http://www.affymetrix.com/support/down
loads/manuals/
expression_analysis_technical_manual.pdf. MIAME-com-
pliant data are available through ArrayExpress and GEO
databases http://www.ebi.ac.uk/microarray-as/ae/, acces-
sion: E-MEXP-1595; http://www.ncbi.nlm.nih.gov/
projects/geo/, accession: GSE11497). Based on AffyGCQC
program QC assessment [27], hybridizations of biological
duplicates were retained for downstream analysis. Raw
data were pre-processed to obtain expression values using
GC-RMA algorithm [28]. Unreliable probe-sets called
"absent" by Affymetrix GCOS software http://
www.affymetrix.com/support/downloads/manuals/
data_analysis_fundamentals_manual.pdf for at least 3
GeneChips out of 4 were discarded, as well as probe-sets
called "absent" once within samples plus once within
controls. LPE tests [29] were performed to identify signif-
icant differences in gene expression between parasite-free
and parasite-harbouring MΦ. Benjamini-Hochberg (BH)
multiple-test correction [30] was applied to control for the
number of false positives with an adjusted 5% statistical
significance threshold. A total of 1,248 probe-sets show-
ing significant differential expression were input into
Ingenuity Pathway Analysis software v5.5.1 http://
www.ingenuity.com to perform a biological interaction
network analysis. Although a cross-hybridization study
was performed by Gregrogy and coworkers (11) on a
mouse U74av2 DNA Affymetrix gene chip (12,488 tran-
scripts) with RNA from Leishmania donovani, it was impor-
tant to also assess the absence of significant cross-
hybridization in our experimental conditions. To this
end, we compared the gene chip data obtained with MΦ
RNA alone with those obtained with the same RNA prep-
aration spiked with different amount of L. amazonensis
RNA. Our data showed that L. amazonensis RNA did not
interfere with mouse RNA hybridization onto GeneChips
(data not shown). Indeed, fold-change values for a techni-
cal replicate of mouse RNA were not significantly differentBMC Genomics 2009, 10:119 http://www.biomedcentral.com/1471-2164/10/119
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from those observed for mouse RNA spiked with up to
10% of L. amazonensis RNA taking the non-spiked mouse
RNA as reference (one-sample one-sided Student's t-test
P-values < 5% for all 45,101 probe-sets, the 1,248 signifi-
cantly modulated probe-sets, the probe-sets of the 107
genes in Table 1 and the probe-sets of the 13 genes in Fig-
ure 3). Therefore, the observed over-expressions were not
due to cross-hybridization between the mouse and the
amastigote transcripts, thus providing valid information
about the reprogramming of MΦ hosting cell-cycling
amastigotes.
Real-time quantitative PCR
RTQPCR were performed on cDNA from various biologi-
cal samples including those used for the hybridizations
using a LightCycler®480 (Roche Diagnostics). Primer
sequences are available upon request. Gene expression
analysis using qBase [31] allowed determining the nor-
malized relative quantities between parasite-free and par-
asite-harbouring MΦ.
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